VVMF - Viral Vector Manufacturing Facility

Today is Jeans for Genes Day! An iconic and important fund raising campaign supporting research that helps diagnose, understand, and find cures or treatments for conditions affecting kids. Donations enable world-leading research in the areas of cancer, neurobiology, embryology, proteogenomics and gene therapy. Donate today: https://lnkd.in/gFmEqTH Children's Medical Research Institute #JeansforGenes

VVMF - Viral Vector Manufacturing Facility and Cell Therapies Pty Ltd enters strategic collaboration. Viral Vector Manufacturing Facility Pty. Ltd. (VVMF) and Cell Therapies Pty Ltd have co-signed a memorandum of understanding (MoU) to explore strategic collaboration opportunities aimed at strengthening the onshore development and manufacture of Advanced Therapy Medicinal Products (ATMPs). This partnership underscores a shared commitment to expanding access to ATMPs for both Australian and International patients through clinical trials. The MoU also affirms joint efforts to advance capabilities across Australia’s cell and gene therapy (CGT) sector – bolstering support for the growing global CGT market and driving innovation and manufacturing capacity for the Asia Pacific (APAC) region. For more information --> https://lnkd.in/dkEHBkig Stephen Thompson, Bev Menner #VVMF #UnlockingtheFutureofMedicine #CellTherapies #ATMP #CellandGeneTherapy #Australia #CDMO #biomanufacturing

Congratulations Ian Alexander

VVMF - Viral Vector Manufacturing Facility had a successful week at the Bio International Conference 2025. Unlocking the Future of Medicine As Australia's only VV CDMO, we were proud to show case how we are helping to bring cell and gene therapy to the world. Our CEO, Stephen Thompson, and Head of Business Development and Partnerships, Anita van der Meer, enjoyed engaging discussions across partnering sessions, round tables, and at the vibrant Australian Pavilion. A heartfelt thank you to everyone in the Australian delegation whose hard work, collaboration, and energy made this week such a success. Investment NSW, NSW Health, Australian Trade and Investment Commission (Austrade), MTPConnect, AusBiotech #BIO25 #TheWorldCantWait #UnlockingtheFutureofMedicine

VVMF - Viral Vector Manufacturing Facility's CEO, Stephen Thompson was pleased to represent the Australian advanced manufacturing and life sciences sector at the Australia–UK Bilateral Biotech Roundtable at #BIO2025, hosted by AusBiotech. Wonderful to see the signing of the MoU between AusBiotech and BioIndustry Association (BIA) to further strengthen the strong collaboration between Australia and the UK on development and commercialisation within the Biotech sector. #BIO25 #Biotechnology #UnlockingtheFutureofMedicine

All eyes were on Australia as a global hub for medical research, clinical trials, and advanced manufacturing at the Australian Business & Networking Welcome Reception, held at the Museum of Science, Boston. MTPConnect chair The Hon. Jaala Pulford GAICD, welcomed colleagues and guests to kick off the Australian delegation at BIO Convention 2025. As a priority sector for the Australian economy, Life Sciences is well-represented in Boston with a broad contingent of Industry and Government delegates coming together to show case Australia's capabilities. Rebekah Cassidy, Erica Bremner Kneipp, Anne O'Neill FTSE, Hanh Hoang, Stephen Thompson, Anita van der Meer #MTPConnect #BIO25 #TheWorldCantWait #Australia #InvestmentNSW #NSWMedicalResearch #AUStrade #VVMF #UnlockingtheFutureofMedicine #CDMO #biomanufacturing #CellandGeneTherapy

Members of the VVMF - Viral Vector Manufacturing Facility process development team - Dr Ted Chang, Dr Sharon Cunningham, Margot Latham, and Ben Kalma (also BPN committee member), were inspired by the innovations in food and agritechnology at The Bioprocessing Network NSW networking event, in Sydney, hosted by Vow.  A huge thank you to the team at Vow for their generosity in showcasing their cutting edge production facility.  Vow exemplifies the diversity within New South Wales' advanced biomanufacturing sector. #BPN #BPN2025 #vow #biomanufacturing #VVMF

We are on our way to Bio! Momentum was building in Sydney, at the pre-departure briefing for the New South Wales (NSW) Going Global Program - Health to the United States of America. A standout contingent of businesses were welcomed by Warwick Scherf, Director of Export, Investment NSW, with Anne O'Neill, Director Commercialisation & Strategic Partnerships, NSW Health, outlining NSW Health's priorities. Anne O'Neill shared: ''NSW Health and Investment NSW are teaming up again to take an impressive NSW delegation to BIO 2025, in Boston. Visit the team at the Australian Pavilion to discuss opportunities to invest, collaborate and partner in NSW." A big thankyou to Investment NSW's Shaun McAlpine, Daniel Meninelli, and Hanh Hoang for their leadership and guidance throughout this program. Stephen Thompson, VVMF CEO, and Anita van der Meer, Head of Business Development and Partnerships, will be attending BIO 2025, taking place June 16-19 at the Boston Convention and Exhibition Center, USA. To find out more about VVMF - Viral Vector Manufacturing Facility, 🤝 Join them at the 📍Australian Pavilion 📅 Schedule a meeting via the Bio International Conference one-on-one partnering platform 📧 Contact us at info@vvmf.com.au #BIO2025 #TheWorldCantWait  #InvestmentNSW #NSWMedicalResearch #AUStrade  #MTPConnect #NSW #VVMF #UnlockingtheFutureofMedicine #biomanufacturing #CellandGeneTherapy #Australia #CDMO

"Australia is stepping up as a regional powerhouse in biomanufacturing". Read how VVMF - Viral Vector Manufacturing Facility's CEO, Stephen Thompson and Cytiva's General Manager, Australia & New Zealand, Jon Ince, are partnering to deliver Australia’s first commercial scale viral vector manufacturing facility. Stephen Thompson will be at the Bio International conference 2025, in Boston. 📅 June 16-19th at the Boston Convention & Exhibition Center, USA. To find out more about VVMF, join Stephen and Head of Business Development and Partnerships, Anita van der Meer, at the Australian Pavillion, schedule a meeting via the Bio International Conference one-on-one partnering platform or contact us at info@vvmf.com.au #VVMF #UnlockingtheFutureofMedicine #Cytiva #biomanufacturing #CellandGeneTherapy #Australia #CDMO #BIO25 #TheWorldCantWait #AUStrade #InvestmentNSW #MTPConnect

VVMF - Viral Vector Manufacturing Facility welcomed Penny Shakespeare and Jean-Frederic Levesque accompanied by members of the Federal and NSW Health departments, OHMR, and Westmead Health Precinct to tour our facility. We were excited to showcase the progress we have made in building the first commercial-scale Viral Vector manufacturing facility in Australia.   Together with Children's Medical Research Institute, The Westmead Institute for Medical Research, and NSW Health we highlighted how the Westmead Health Precinct works together to improve patient outcomes and accelerates the clinical delivery of advanced therapeutic applications. Australian Government Department of Health, Disability and Ageing, Western NSW Local Health District, NSW Medical Research #VVMF #CMRI #WIMR #SCHN #WestmeadHospital #UnlockingtheFutureofMedicine #ViralVectors #CellandGeneTherapy #CDMO #AustralianAdvantage